Prognostic Evaluation for Gastroenteropancreatic NEC: AJCC or ENETS Staging Classification or Others?
Introduction: For poorly-differentiated gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC), American Joint Committee on Cancer (AJCC) recommends to use a classification different from that for well-differentiated neuroendocrine tumor. However, this is not adopted by European Neuroendocrine Tumor Society (ENETS) staging classification.
Aim(s): To explore a classification which can better evaluate the prognosis of GEP-NEC.
Materials and methods: Patients with NEC from stomach, colorectum and pancreas were retrieved from SEER database and our multicenter cohort. Harrel’s concordance index (C-index) was used to calculate predictive accuracy.
Conference: 17th Annual ENETSConcerence (2020)
To read the full abstract, please log into your ENETS Member account.